Trump Announces Drug Price Deal With Regeneron
6 days ago
President Donald Trump is announcing a new agreement with drugmaker Regeneron aimed at lowering prescription drug costs in the United States.
The deal includes reduced prices for certain medications covered under Medicaid, as well as a discounted cholesterol drug that will be offered through the administration’s online platform.
Officials say the agreement is part of a broader effort to align U.S. pharmaceutical prices more closely with lower costs in other developed countries.
More details are expected to be shared with Congress in the coming weeks.
The deal includes reduced prices for certain medications covered under Medicaid, as well as a discounted cholesterol drug that will be offered through the administration’s online platform.
Officials say the agreement is part of a broader effort to align U.S. pharmaceutical prices more closely with lower costs in other developed countries.
More details are expected to be shared with Congress in the coming weeks.
